← Back to Search

Insulin Pump

t:slim X2 insulin pump with Control-IQ technology 1.5 for Type 1 Diabetes

N/A
Waitlist Available
Research Sponsored by Tandem Diabetes Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial looked at the t:slim X2 insulin pump with Control-IQ technology to see how well it worked in people with type 1 diabetes who needed to use a high basal rate.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse device effects
Diabetic ketoacidosis
Other serious adverse events
+1 more
Secondary outcome measures
Adverse events
Glucose < 54 mg/dL
Glucose < 70 mg/dL
Other outcome measures
CGM Metrics by Time of Day
CGM mean glucose
Coefficient of Variation
+6 more

Side effects data

From 2016 Phase 4 trial • 85 Patients • NCT01970241
21%
Hypoglycemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
NPH With Corticosteroid
Control

Trial Design

1Treatment groups
Experimental Treatment
Group I: t:slim X2 insulin pump with Control-IQ technologyExperimental Treatment1 Intervention
Adults with type 1 diabetes will use the t:slim X2 insulin pump with Control-IQ technology 1.5 for 3-months of outpatient use. Meal and exercise challenges will be performed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
t:slim X2 insulin pump with Control-IQ technology 1.5
2022
N/A
~220

Find a Location

Who is running the clinical trial?

Tandem Diabetes Care, Inc.Lead Sponsor
37 Previous Clinical Trials
5,653 Total Patients Enrolled
Jordan Pinsker, MDStudy DirectorTandem Diabetes Care
10 Previous Clinical Trials
3,854 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any Canadian facilities currently conducting this investigation?

"This medical study is running at four different locations, such as the Rocky Mountain Diabetes Center in Idaho Falls and International Diabetes Center in Minneapolis. Additionally, there are two other centres: Diabetes & Endocrine Treatment Specialists in Sandy."

Answered by AI

Are researchers still welcoming new participants to this experiment?

"Affirmative. According to clinicaltrials.gov, this investigation into a new medical intervention began on 29th June 2022 and was recently updated in August of the same year. At present, 60 individuals are being sought from 4 different healthcare centres for participation."

Answered by AI

How many individuals have elected to partake in this research endeavor?

"In order to commence this trial, 60 individuals must meet the criteria of eligibility. Sponsored by Tandem Diabetes Care, Inc., patient recruitment will take place across two sites--Rocky Mountain Diabetes Center in Idaho Falls and Diabetes & Endocrine Treatment Specialists located in Sandy, Utah."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
How old are they?
18 - 65
What site did they apply to?
Barbara Davis Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)
2022. "Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05422053.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top